Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Pompiliu Piso, Wim Ceelen, Ignace H. J. T. de Hingh, Diane Goéré, François Quenet, P. Barrios, Olivier Glehen, Armando Sardi, Marcello Deraco, B. J. Moran, Dario Baratti, Kurt Van der Speeten, Yutaka Yonemura, David L. Morris, Edward A. Levine, Shigeki Kusamura, Joerg O.W. Pelz, Francesco Barretta, A. Gomez-Portilla, Paul H. Sugarbaker, Eran Nizri, Santiago González-Moreno, Laurent Villeneuve
Publikováno v:
JAMA Surgery. 156:e206363
Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei (PMP) are currently not available.To evaluate outcomes after cytoreductive surgery (CRS) and HIPEC compared with CRS alone in patients with
Autor:
John Aversa, Thomas F. Seykora, Elijah Dixon, Stephen W. Behrman, Amer H. Zureikat, Stacy J. Kowalsky, Adam C. Berger, Roberto Salvia, Tara S. Kent, Valentina Allegrini, Martha Navarro Cagigas, Michael G. House, Chad G. Ball, Robert H. Hollis, Paxton V. Dickson, Mollie R. Freedman-Weiss, William E. Fisher, Courtney E. Barrows, Brett L. Ecker, Carl Schmidt, Francisco Guzman-Pruneda, Charles M. Vollmer, Giuseppe Malleo, John D. Christein, Ronald R. Salem, Richard Zheng
Publikováno v:
Hepatobiliary Surg Nutr
Importance Ampullary adenocarcinoma is a rare malignant neoplasm that arises within the duodenal ampullary complex. The role of adjuvant therapy (AT) in the treatment of ampullary adenocarcinoma has not been clearly defined. Objective To determine if
Autor:
Maheswari Senthil, John Morgan, Laurel A. Guthrie, Majed M Ramadan, Carlos A. Garberoglio, Matthew J. Selleck, Mark E. Reeves, Mayada Aljehani, Brice Jabo, Khaled Bahjri, Sharon S. Lum
Publikováno v:
JAMA Surgery. 153:60
Biologic therapy (BT) (eg, bevacizumab or cetuximab) is increasingly used to treat metastatic colorectal cancer (mCRC). Recent investigations have suggested that right- or left-sided primary tumor origin affects survival and response to BT.To evaluat